Skip to main content
. 2022 Feb 21;29(5):2805–2811. doi: 10.1245/s10434-022-11416-4

Table 8.

Survival (percentage and 95% confidence intervals) between 6 and 10 years after surgery for esophageal cancer, excluding patients with diagnoses related to heavy smoking tobacco and alcohol abuse

Year Number Observed survival Relative survival
Total
6 652 94.3 (92.6–96.1) 96.8 (94.9–98.6)
7 562 89.5 (87.1–91.9) 94.1 (91.5–96.6)
8 466 85.2 (82.4–88.1) 92.1 (89.0–95.2)
9 406 81.3 (78.0–84.5) 90.3 (86.7–93.9)
10 344 76.1 (72.4–79.8) 87.1 (82.8–91.3)
Adenocarcinoma
6 441 94.8 (92.7–96.9) 97.4 (95.2–99.5)
7 374 90.1 (88.0–93.5) 95.7 (92.7–98.6)
8 303 87.1 (83.8–90.5) 94.9 (91.2–98.5)
9 259 85.5 (81.9–89.0) 96.1 (92.0–100.0)
10 219 80.0 (75.7–84.3) 93.1 (88.1–98.2)
Squamous cell carcinoma
6 206 93.2 (89.8–96.6) 95.3 (91.8–98.9)
7 183 86.6 (81.9–91.3) 90.5 (85.6–95.4)
8 160 81.2 (75.7–86.7) 86.5 (80.7–92.4)
9 144 73.3 (67.0–79.6) 79.7 (72.8–86.6)
10 122 68.5 (61.8–75.2) 76.0 (68.6–83.5)